Abstract:Background: Integrin Beta 4 (ITGB4), a member of the integrin family, was found to be abnormally highly expressed in colorectal cancer tissues and serum in our previous research, and it was associated with clinicopathological types and overall survival. This study further explores the potential mechanisms of ITGB4 in the occurrence and development of colorectal cancer, seeks downstream target genes and signaling pathways, and provides new insights for precision treatment of colorectal cancer. Methods: Through bioinformatics analysis, it was verified that ITGB4 and EZR are highly expressed in tumor tissues of CRC patients and are associated with poor patient prognosis. The effects of ITGB4 on the proliferation, migration, invasion, and apoptosis of CRC cells were validated using CCK-8, wound healing assay, Transwell migration, and invasion assays. A nude mouse tumor formation experiment was conducted to validate the tumor-promoting effect of ITGB4 in vivo. Transcriptome sequencing was performed in SW480 cells with ITGB4 knockdown, and potential downstream targets and signaling pathways of ITGB4 were screened using KEGG enrichment analysis and bioinformatics analysis. The interaction between ITGB4 and downstream target genes was further demonstrated by immunofluorescence co-staining and co-immunoprecipitation. Key proteins in the downstream signaling pathway (β-catenin, c-Myc, and cyclinD1) were detected by Western blot to clarify the potential signaling pathway through which ITGB4 functions in CRC. Rescue experiments were conducted to validate the role of ITGB4 and its downstream target genes in the proliferation, migration, and invasion of colorectal cancer. Results: ITGB4 is highly expressed in CRC tissues and cells. In vitro, downregulation of ITGB4 can inhibit the proliferation, migration, and invasion of CRC cells and promote apoptosis. In vivo, ITGB4 contributes to the growth of CRC tumor tissues and regulates the tumorigenic properties such as proliferation and invasion of CRC cells. Additionally, EZR has been preliminarily identified as a key downstream target of ITGB4, as the effects of ITGB4 knockdown on the proliferation, migration, and invasion of CRC cells can be rescued by overexpressing EZR. We also demonstrated that the ITGB4/EZR axis promotes the occurrence and development of CRC by activating the Wnt/β-catenin signaling pathway and regulating various biological functions of CRC cells. Conclusions: ITGB4 targets and regulates EZR, and by activating the Wnt/β-catenin signaling pathway, it affects the proliferation, migration, and invasion of CRC, suggesting that ITGB4 may become a potential biomarker and therapeutic target.

E74‐like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non‐coding RNA integrin subunit beta 8 antisense RNA 1‐mediated histone H3 lysine 27 trimethylation modification

Aberrantly Expressed Fra-1 by Il-6/Stat3 Transactivation Promotes Colorectal Cancer Aggressiveness Through Epithelial-Mesenchymal Transition

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Lncrna ITGB8-AS1 Functions As a Cerna to Promote Colorectal Cancer Growth and Migration Through Integrin-Mediated Focal Adhesion Signaling.

FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC

ITGB4 promotes the progression of colorectal cancer by activating Wnt/β-catenin signaling pathway via targeting EZR

Abstract 991: Long Non-Coding RNA LINC01133 Inhibits Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription

IL-13/STAT6 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Colorectal Cancer Cells.

NBPF4 Mitigates Progression in Colorectal Cancer Through the Regulation of EZH2-associated ETFA

Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression

ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.

Comprehensive Analysis of E47‑like Factors and Verification of ELF4 in Clear Cell Renal Cell Carcinoma.

Circ_0022340 promotes colorectal cancer progression via HNRNPC/EBF1/SYT7 or miR-382-5p/ELK1 axis

MYC-induced upregulation of lncRNA ELFN1-AS1 contributes to tumor growth in colorectal cancer via epigenetically silencing TPM1.

LncRNA HOXB-AS4 promotes proliferation and migration of colorectal cancer via the miR-140-5p/hdac7 axis

LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages

Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis

LINC00857 promotes colorectal cancer progression by sponging miR-150-5p and upregulating HMGB3 (high mobility group box 3) expression

RNA-binding Protein CELF1 Enhances Cell Migration, Invasion, and Chemoresistance by Targeting ETS2 in Colorectal Cancer

ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood